SEC Form 4 · accession 0001127602-18-012374
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & CEO · Director
Period of report
Mar 19, 2018
Accepted (ET)
Mar 21, 2018 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 19, 2018 | M | 21,512 | $52.65 | A | 21,652 | D | |
| Common StockF2 | Mar 19, 2018 | S | 21,390 | $110.0254 | D | 262 | D | |
| Common StockF3 | Mar 19, 2018 | S | 122 | $111.6077 | D | 140 | D | |
| Common Stock | Mar 20, 2018 | M | 301 | $52.65 | A | 441 | D | |
| Common Stock | Mar 20, 2018 | S | 100 | $110.44 | D | 341 | D | |
| Common Stock | Mar 20, 2018 | S | 100 | $110.48 | D | 241 | D | |
| Common Stock | Mar 20, 2018 | S | 100 | $110.52 | D | 141 | D | |
| Common Stock | Mar 20, 2018 | S | 1 | $111.10 | D | 140 | D | |
| Common Stock | holding | — | — | — | 683,489 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $52.65 | Mar 19, 2018 | M | 21,512 | D | Dec 31, 2009 | Dec 31, 2019 | Common Stock | 21,512 | 301,171 | D |
| Stock Options | $52.65 | Mar 20, 2018 | M | 301 | D | Dec 31, 2009 | Dec 31, 2019 | Common Stock | 301 | 300,870 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2This transaction was executed in multiple trades at prices ranging from $110.00 to $110.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $111.375 to $111.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.